The release of Semaglutide at a 45mg strength represents a significant development in treating high blood sugar. Previously, smaller doses were usually administered, but this latest formulation provides the potential for greater blood sugar control in many people. Doctors are evaluating its effectiveness and well-being profile, specifically in pati